Clinical Challenges of IBD Management: Racial Disparities in IBD and COVID Updates
Released On
January 19, 2023
Expires On
November 3, 2023
Media Type
Internet
Completion Time
15 minutes
Specialty
Gastroenterology, Family Medicine, Internal Medicine
Topic(s)
IBD
This activity is jointly provided by American Gastroenterological Association and Partners for Advancing Clinical Education in partnership with Practicing Clinicians Exchange and Clinical Care Options, LLC.
This activity is supported by an educational grants from Amgen, Inc, Ferring Pharmaceuticals, Inc., and Takeda Pharmaceuticals U.S.A., Inc.
Credit Available
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit(s)™
- Nurse Practitioners — 0.25 Nursing Contact Hours, includes 0.25 hur of pharmacology credit
- Physician Assistants/Physician Associates — 0.25 AAPA Category 1 CME Credit
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This program is intended for the IBD care team including gastroenterologists, advanced practice providers that specialize in gastroenterology, internal medicine and family medicine physicians and advanced practice providers, nurses and other HCPs involved in the care of patients living with IBD.
Program Overview
The goal of this multicomponent, multiformat curriculum is to improve the knowledge and competence of community HCPs who care for patients living with ulcerative colitis and Crohn’s disease.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply strategies to reduce racial disparities impacting patients with IBD
- Summarize the latest recommendations and best practices for the management of IBD during COVID-19
Faculty
Abigail Meyers, PA-C
Instructor in Surgery
Physician Assistant
Colon and Rectal Surgery
Mayo Clinic
Rochester, Minnesota
Physician Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Joint Accreditation Statement
In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Credit Designation
The AGA Institute designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Credit Designation
Nursing contact hours: 0.25, which includes 0.25 hours of pharmacology credit
Nurse Course Advisor: Kimberly Kearns, MS, APN-BC, Duly Health and Care, Hoffman Estates, Illinois
AAPA Credit Designation
Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until November 3, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA Course Advisor: Abigail Meyers, PA-C, Mayo Clinic, Rochester, Minnesota
Disclosures of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
- Abigail Meyers, PA-C
- has no relevant financial relationships to disclose
The planners and content peer reviewers from Partners for Advancing Clinical Education, the American Gastroenterological Associate, Practicing Clinicians Exchange, and Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Bruce E. Sands, MD, MS and Kimberly Kearns, MS, APN-BC as noted below:
- Bruce E. Sands, MD, MS:
- Consultant/Advisor/Speaker: AbbVie, Amgen, Arena Pharmaceuticals, AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Celltrion, Fresenius Kabi, Genentech, GlaxoSmithKline, Janssen, Lilly, Merck, Pfizer, Sun Pharma, Takeda, Teva
- Kimberly Kearns, MS, APN-BC:
- Consultant/Advisor/Speaker: Lilly, Janssen, Salix
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. Learners wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete evaluation form
The estimated time to complete this activity is 0.25 hours.
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 65%.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For CME questions please contact: ceasupport@cealliance.com.